Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 5/20 | 0.54 |
| ▸ | WDR77 | Q9BQA1 | 5/20 | 0.54 |
| ▸ | AHCY | P23526 | 4/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.46 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2403046 | 0.88 | PRMT5 (0.52) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL226039 | 0.87 | AHCY (0.63) | AHCYADORA3ADORA2BDOT1L | |
| SCHEMBL3515656 | 0.87 | PRMT5 (0.50) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL4308125 | 0.86 | DNPH1 (0.48) | PRMT5WDR77AHCY | |
| SCHEMBL10365540 | 0.85 | PRMT5 (0.58) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL30394512 | 0.84 | PRMT5 (0.48) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL5782783 | 0.84 | PRMT5 (0.48) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL8441738 | 0.82 | P2RY2 (0.52) | — | |
| SCHEMBL28672423 | 0.82 | PRMT5 (0.53) | PRMT5WDR77AHCYADORA3ADORA2B | |
| SCHEMBL6538405 | 0.82 | PRMT5 (0.53) | PRMT5WDR77AHCYADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4395901-A1 | COMPOSITIONS AND METHODS FOR MODULATING KRAS EXPRESSION | Molecular Axiom, LLC (US) | 2024-07-10 | — | — | EP | disclosed |
| WO-2024113009-A1 | AGENTS, COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY | THE UNIVERSITY OF QUEENSLAND (AU) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024118866-A1 | GPC3-SPECIFIC ANTIBODIES, BINDING DOMAINS, AND RELATED PROTEINS AND USES THEREOF | MODERNATX, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| EP-4370165-A2 | GENE EDITING TO IMPROVE JOINT FUNCTION | Orthobio Therapeutics, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4366770-A1 | P7 CONTAINING NUCLEOSIDE-MODIFIED MRNA-LIPID NANOPARTICLE LINEAGE VACCINE FOR HEPATITIS C VIRUS | The Trustees of the University of Pennsylvania (US) | 2024-05-15 | — | — | EP | disclosed |
| EP-4320237-A1 | OLIGONUCLEOTIDES | Hudson Institute of Medical Research (AU) | 2024-02-14 | — | — | EP | disclosed |
| WO-2022256516-A9 | GENE EDITING THERAPY FOR HIV INFECTION VIA DUAL TARGETING OF HIV GENOME AND CCR5 | TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-02-01 | — | — | WO | disclosed |
| WO-2024020453-A2 | IMMUNE SYSTEM MODULATORS AND USES THEREOF | HDT BIO CORP. (US) | 2024-01-25 | — | — | WO | disclosed |
| EP-4277651-A1 | <SMALLCAPS/>? ? ?STAPHYLOCOCCUS? ? ? ? ?AUREUS ANTIGEN-BASED NUCLEIC ACID VACCINES | University of Rochester (US) | 2023-11-22 | — | — | EP | disclosed |
| WO-2023183569-A1 | METHODS AND APPARATUS FOR SYNTHESIZING NUCLEIC ACIDS | Molecular Assemblies, Inc. (US) | 2023-09-28 | — | — | WO | disclosed |
| WO-2017127750-A1 | MESSENGER RIBONUCLEIC ACIDS FOR THE PRODUCTION OF INTRACELLULAR BINDING POLYPEPTIDES AND METHODS OF USE THEREOF | MODERNATX, INC. (US) | 2017-07-27 | — | — | WO | disclosed |
| WO-2017120612-A1 | THERAPEUTIC MRNAS ENCODING ANTI CTLA-4 ANTIBODIES | MODERNATX, INC. (US) | 2017-07-13 | — | — | WO | disclosed |
| WO-2017093969-A1 | COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY | NOVARTIS AG (CH) | 2017-06-08 | — | — | WO | disclosed |
| EP-3171895-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES | Modernatx, Inc. (US) | 2017-05-31 | — | — | EP | disclosed |
| CN-106421773-A | VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES | 诺华股份有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-106459995-A | CRISPR-associated methods and compositions using dominant grnas | 爱迪塔斯医药有限公司 | 2017-02-22 | — | — | CN | disclosed |
| CN-103384515-B | Lipids suitable for liposomal delivery of protein-coding RNA | 诺华有限公司 | 2017-02-15 | — | — | CN | disclosed |
| WO-2017011773-A2 | CODON-OPTIMIZED NUCLEIC ACIDS ENCODING ANTIBODIES | MODERNATX, INC. (US) | 2017-01-19 | — | — | WO | disclosed |
| WO-2016070070-A1 | RNA GUIDED ERADICATION OF HUMAN JC VIRUS AND OTHER POLYOMAVIRUSES | TEMPLE UNIVERSITY OF THE COMMONWEALTH (US) | 2016-05-06 | — | — | WO | disclosed |
| WO-2016014846-A1 | MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF INTRABODIES | MODERNA THERAPEUTICS, INC. (US) | 2016-01-28 | — | — | WO | disclosed |